HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5
HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5
HC Wainwright & Co.以买入评级开始对ZyVersa Therapeutics进行保险，宣布目标股价为2.5美元
HC Wainwright & Co. analyst Ed Arce initiates coverage on ZyVersa Therapeutics (NASDAQ:ZVSA) with a Buy rating and announces Price Target of $2.5.
HC Wainwright & Co. 分析师埃德·阿尔塞以买入评级开始对ZyVersa Therapeutics（纳斯达克股票代码：ZVSA）进行报道，并宣布目标股价为2.5美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。